Human Medicines European Public Assessment Report (EPAR): Vepacel, Prepandemic Influenza Vaccine (H5N1) (Whole Virion, Inactivated,prepared in Cell Culture), Influenza, Human,Immunization,Disease Outbreaks, Date of Authorisation: 17/02/2012, Revision: 9, Status: Authorised

Case Medical Research
doi 10.31525/cmr-962c3e
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Colobreathe, Colistimethate Sodium, Cystic Fibrosis, Date of Authorisation: 13/02/2012, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Jevtana, Cabazitaxel, Prostatic Neoplasms, Date of Authorisation: 17/03/2011, Revision: 17, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Bronchitol, Mannitol, Cystic Fibrosis, Date of Authorisation: 13/04/2012, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Revinty Ellipta, Fluticasone Furoate / Vilanterol, Asthma, Date of Authorisation: 02/05/2014, Revision: 16, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Betmiga, Mirabegron, Urinary Bladder, Overactive, Date of Authorisation: 20/12/2012, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Xgeva, Denosumab, Fractures, Bone,Neoplasm Metastasis, Date of Authorisation: 13/07/2011, Revision: 17, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Twinrix Paediatric, Hepatitis-A (Inactivated) and Hepatitis-B (rDNA) (HAB) Vaccine (Adsorbed), Immunization,Hepatitis B,Hepatitis A, Date of Authorisation: 10/02/1997, Revision: 20, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Pixuvri, Pixantrone Dimaleate, Lymphoma, Non-Hodgkin, Date of Authorisation: 10/05/2012, Revision: 19, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy